|
|
|
Volumn 24, Issue 1 Suppl 5, 1997, Pages
|
|
Topotecan and the treatment of recurrent ovarian cancer: is there a role for granulocyte colony-stimulating factor?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DNA TOPOISOMERASE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
GRANULOCYTE COLONY STIMULATING FACTOR;
TOPOTECAN;
BONE MARROW;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
HUMAN;
NEUTROPENIA;
OVARY TUMOR;
REVIEW;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS;
BONE MARROW;
CAMPTOTHECIN;
CLINICAL TRIALS;
DNA TOPOISOMERASES, TYPE I;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
ENZYME INHIBITORS;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
NEUTROPENIA;
OVARIAN NEOPLASMS;
TOPOTECAN;
|
|
EID: 0031064505
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (24)
|
